⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OKYO News
OKYO Pharma Limited Ordinary Shares
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
globenewswire.com
OKYO
OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium
globenewswire.com
OKYO
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
globenewswire.com
OKYO
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
globenewswire.com
OKYO
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
globenewswire.com
OKYO
OKYO Pharma Announces Chairman and Founder Acquires Shares
globenewswire.com
OKYO
OKYO Pharma Announces Director Acquires Shares
globenewswire.com
OKYO
OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
globenewswire.com
OKYO
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
globenewswire.com
OKYO
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
globenewswire.com
OKYO